摘要
Abstract
Objective Focus on refractory type 2 diabetes mellitus in the clinical treatment combination door winter insulin 30 and the effectiveness of lalu peptide.Methods Selected 81 cases of intractable type 2 diabetes,in January 2014-August 2016 in shandong demian Texas hospital medical treatment of patients,randomly assigned in different treatments:39 cases in group A combination door winter 30 and specially insulin,insulin and 42 cases of group B combination door winter insulin 30 and the lalu peptide,give compared two groups of medicine quality and its safety.Results 39 cases in group A effectiveness 74.36％,42 cases in group B is 95.24％,(P<0.05).Conclusion When the refractory patients with type 2 diabetes treatment,combination door winter insulin 30 high and the effectiveness of lalu peptide,recommended.关键词
地特胰岛素/难治性2型糖尿病/门冬胰岛素30/不良症状/利拉鲁肽Key words
Specially insulin/Refractory for type 2 diabetes/Door winter insulin 30/Adverse symptoms/The lalu peptide分类
医药卫生
